SCHEMBL13352362

SCHEMBL13352362

Nc1cc(OSO)c(N)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.54
KMT2A Q03164 7/20 0.54
MAPT P10636 6/20 0.54
THRB P10828 4/20 0.54
MAPK1 P28482 4/20 0.54
NPSR1 Q6W5P4 3/20 0.54
MCL1 Q07820 3/20 0.54
PKM P14618 2/20 0.54
KDM4E B2RXH2 2/20 0.54
USP2 O75604 2/20 0.54
GRK6 P43250 1/20 0.54
ADORA2A P29274 6/20 0.49
CSNK1A1 P48729 2/20 0.49
CSNK1D P48730 2/20 0.49
CSNK1G1 Q9HCP0 2/20 0.49
MAOA P21397 2/20 0.49
FGR P09769 1/20 0.49
PIM1 P11309 1/20 0.49
DYRK1A Q13627 1/20 0.49
HIPK2 Q9H2X6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460432 0.80 MAPT (0.66) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL11345777 0.79 MEN1 (0.61) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL92415 0.77 ADORA2A (0.66) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL11023123 0.77 MEN1 (0.55) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL8729470 0.77 MEN1 (0.51) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL11155643 0.75 MEN1 (0.47) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL10906307 0.75 ADORA2A (0.52) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL8734315 0.75 ADORA2A (0.52) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL10817109 0.75 ADORA2A (0.55) MEN1KMT2AMAPTTHRBMAPK1
SCHEMBL11759211 0.74 ADORA2A (0.45) MEN1KMT2AMAPTTHRBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130505-A1 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIVERSITY OF ROCHESTER (US) 2010-05-27 US disclosed
WO-2009020677-A9 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIV ROCHESTER (US) 2009-04-16 WO disclosed
WO-2009020677-A2 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING UNIVERSITY OF ROCHESTER (US) 2009-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130505-A1 COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING GNAI1, GNAI3, GNAI2 MEN1 3515/4885KMT2A 4394/4885MAPT 3637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.